Sponsor or institution
Clinical trials and research at Bolder Biotechnology, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Developing a treatment for radiation exposure that works up to 48 hours later
This study is testing a new treatment called BBT-059 that could help people who have been exposed to radiation and need medical help even after other treatments are no longer an option, and we're making sure it's safe before moving on to human trials.
-
New drug combinations to improve survival after radiation exposure
This study is looking at new combinations of drugs, including one called PEG IL-11, to see if they can help people who have been exposed to high levels of radiation and are experiencing acute radiation syndrome, especially when treatment starts 48 hours after exposure.
-
Finding new ways to improve survival from a dangerous bacterial infection.
This study is looking for new ways to help your body fight off a dangerous germ called Burkholderia pseudomallei, which causes melioidosis, by boosting your immune system, especially in emergencies when current antibiotics might not work well.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.